Charts Revium Rx.

Stocks

Delayed OTC Markets 14:30:09 30/03/2026 BST			5-day change	1st Jan Change
1.670 ^USD	+11.33%		-.--%	+221.15%

08-13	Revium Rx. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-22	Revium Rx. Announces Resignation of Inna Martin from Director, Chief Operating Officer and President, Effective June 16, 2026	CI

Stock exchange

OTC Markets RVRC 1.670 $ +11.33% 167 $

ProRealTime Chart